Although several protein-protein interactions have been reported between transient receptor potential (TRP) channels, they are all known to occur exclusively between members of the same group. The only intergroup interaction described so far is that of TRPP2 and TRPC1; however, the significance of this interaction is unknown. Here, we show that TRPP2 and TRPC1 assemble to form a channel with a unique constellation of new and TRPP2/ TRPC1-specific properties. TRPP2/TRPC1 is activated in response to G-protein-coupled receptor activation and shows a pattern of single-channel conductance, amiloride sensitivity and ion permeability distinct from that of TRPP2 or TRPC1 alone. Native TRPP2/TRPC1 activity is shown in kidney cells by complementary gain-of-function and loss-of-function experiments, and its existence under physiological conditions is supported by colocalization at the primary cilium and by co-immunoprecipitation from kidney membranes. Identification of the heteromultimeric TRPP2/TRPC1 channel has implications in mechanosensation and cilium-based Ca 2 þ signalling.
INTRODUCTION
TRPP2, also called polycystin 2, belongs to the polycystin subgroup of transient receptor potential (TRP) superfamily (Delmas, 2004 (Delmas, , 2005 Montell, 2005; Nilius & Voets, 2005; Giamarchi et al, 2006; Kö ttgen, 2007) and was originally cloned because of its involvement in autosomal dominant polycystic kidney disease (ADPKD; Mochizuki et al, 1996) . Naturally occurring mutations in TRPP2 are responsible for approximately 15% of all cases of ADPKD, which is one of the most common genetic diseases primarily affecting the kidney. TRPP2 forms a highly conductive cation channel (Gonzalez-Perrett et al, 2001 ) requiring polycystin 1 (PKD1) for its activity (Hanaoka et al, 2000; Delmas et al, 2004) . The channel is highly versatile and is involved in epidermal growth factor-mediated currents (Ma et al, 2005; Tsiokas et al, 2007) , intracellular Ca 2 þ release (Koulen et al, 2002) and mechanodetection (Nauli et al, 2003) in kidney cells.
One of the most exciting properties of TRP channels is their ability to heteromultimerize. The first example, to our knowledge, of a functional interaction between two TRP channels was reported for Drosophila homologues TRP and TRPL (Xu et al, 1997) . Subsequently, protein-protein interactions have been shown for various members of TRPC and TRPV subfamilies (Nilius et al, 2007) . Interestingly, all these interactions occurred exclusively between members of the same group, implicating primary sequence homology as the underlying factor in protein-protein associations.
Long before the functional characterization of TRPP2 or TRPC1, Tsiokas et al (1999) described a protein-protein interaction between them. On the basis of biochemical data, the interaction was mediated by two distinct domains in TRPP2: one involving the carboxy-terminal cytosolic tail, and the other involving a larger domain containing transmembrane segments 2-6 and intervening loops. There is also evidence for the role of TRPC1 in store-and receptor-operated Ca 2 þ entries (Beech, 2005; Ambudkar, 2007; Yuan et al, 2007) . Recently, two further roles of TRPC1 in mechanotransduction (Maroto et al, 2005; Dietrich et al, 2007; Gottlieb et al, 2008) and chemoattraction (Shim et al, 2005; Wang & Poo, 2005) have been reported.
Here, we show that TRPP2 and TRPC1 assemble to form a heteromeric channel with biophysical properties and modes of activation distinct from that of the individual channels. One of the physiological roles of this new channel is to mediate G-proteincoupled receptor (GPCR)-induced conductance in native kidney epithelial cells.
RESULTS AND DISCUSSION Formation of a new GPCR-activated TRP channel
We initiated our studies by testing whether TRPP2 and TRPC1 could form a heteromeric channel in cultured rat sympathetic neurons, using perforated microvesicles ( Fig 1A) . Fig 1B-E shows single-channel activities observed in microvesicles excised from cells expressing TRPP2, PKD1/TRPP2, TRPC1 and TRPP2/TRPC1. Neither application of the PKD1-specific MR3 antibody (n ¼ 9/9), which functions as an activating stimulus , nor stimulation of endogenous B 2 bradykinin receptors (BK, 500 nM; n ¼ 12/12) resulted in channel activation (Fig 1B) . However, TRPP2-like cation channels were activated by MR3 in 21 out of 71 microvesicles isolated from cells expressing PKD1 and TRPP2 (Fig 1C,F) . Mean amplitude at À40 mV was À6.15±0.4 pA (n ¼ 20; Fig 2A) . PKD1/TRPP2 channels did not open in response to exposure to BK (n ¼ 12/12; Fig 1C) . By contrast, BK-but not MR3-activated single-channel events of À0.9 ± 0.1 pA in microvesicles expressing TRPC1 ( Figs 1D,F,2A ). TRPP2 and TRPC1 complementary DNAs microinjected at a ratio of 1:1 resulted in BK-induced cation channels with a mean unitary amplitude at À40 mV of À1.7 ± 0.2 pA (n ¼ 23/38; Fig 2A) . Channels with a mean unitary amplitude of À2.14±0.1 pA (n ¼ 20) were detected in microvesicles derived from cells microinjected with an excess of TRPP2 plasmid compared with TRPC1 (3:1, respectively; Fig 2A) .
Activation of TRPP2/TRPC1 channels by BK was secondary to phospholipase C activation, as pretreatment with U73122 (10 mM for 10 min), but not its inactive analogue, abolished BK-induced channel activity (n ¼ 7/7; data not shown). None A new receptor-operated TRP channel C.-X. Bai et al of the TRPP2/TRPC1-expressing microvesicles responded to MR3 challenge ( Fig 1E) . Single-channel conductance of PKD1/TRPP2, TRPC1 and TRPC1/TRPP2 channels determined under similar recording conditions were 142±2, 16±0.5 and 40±2 pS, respectively (Fig 2B,C) . To provide further evidence for a functional interaction between TRPP2 and TRPC1, single-channel activities were analysed in microvesicles expressing TRPC1 and the channeldead mutant TRPP2-D511V (Fig 2A) . Out of 17 microvesicles challenged with BK, only 4 showed a BK-induced cation current with a unitary amplitude at À40 mV of approximately À1 pA, which was close to that of TRPC1 expressed alone, indicating a dominant-negative effect of TRPP2-D551V on TRPC1. The lack of TRPP2-D511V activity was confirmed by coexpression of PKD1, in which no channel activity was seen in response to MR3 (n ¼ 14/14; Fig 2A,B) .
Pharmacological properties of TRPP2/TRPC1 channels
We compared the effects of lanthanoides on single-channel activities (supplementary Fig 1 online) . When 100 mM La 3 þ was applied to PKD1/TRPP2-expressing cells stimulated with MR3, rapid inhibition of PKD1/TRPP2 channel activity was observed We and others have shown that the PKD1/TRPP2 channel is inhibited by bath application of amiloride (Gonzalez-Perrett et al, 2001 Delmas et al, 2004 ). Therefore, we tested whether amiloride could also inhibit TRPC1 and TRPP2/TRPC1 channels. Consistent with previous results, treatment of PKD1/TRPP2 channels with amiloride (100 mM) increased the number of short flicker closings and reduced single-channel amplitude at À40 mV by approximately 69 ± 2.5% (Fig 3A,D) . Higher concentrations also reduced p o (data not shown). By contrast, amiloride had little effect on TRPC1 current, but reduced TRPP2/TRPC1 single-channel current by 40.7±2% (Fig 3B-D) .
Competition between TRPC1 and PKD1 for TRPP2
As TRPP2 interacted with PKD1 and TRPC1 through the same region in its C-terminal cytoplasmic tail and formed heteromeric channels with different biophysical properties, we tested whether A new receptor-operated TRP channel C.-X. Bai et al PKD1 competed functionally with TRPC1 for binding to TRPP2. Supplementary Fig 3 online shows that expression of PKD1 along with TRPP2 and TRPC1 reduced whole-cell TRPP2/TRPC1 or TRPP2/PKD1 currents activated by BK or MR3, respectively, indicating competition between TRPC1 and PKD1 for TRPP2. These data have implications for the role of TRPC1 in ADPKD and might explain why deletion of TRPC1 did not result in a PKD phenotype. Our data predict that pathological conditions resulting in TRPC1 upregulation could produce PKD-type pathologies.
GPCR activation of TRPP2/TRPC1 in mIMCD3 wells
Next, we studied whether TRPP2/TRPC1 channel complexes exist in mIMCD3 (murine inner medullary collecting duct) kidney cells, which are known to express TRPP2 (Luo et al, 2003) and TRPC1 (supplementary Fig 4B online, lane 2) . Perforated patch-clamp recordings showed that the amplitude of basal currents increased by 3.8 ± 0.7 pA/pF at À80 mV in response to oxotremorine-M (Oxo-M), an M1-muscarinic cholinergic receptor agonist, and was suppressed by 48.3 ± 1.9% by amiloride in native mIMCD3 cells (Fig 4A,E,J,K) . Transfection of TRPP2 alone caused a net increase in the basal activity by À18.3±1.5 pA/pF, no significant activation by Oxo-M (1.4 ± 0.4 pA/pF) and 65.3 ± 1.5% inhibition by amiloride (Fig 4B,F,I -K). Transfection of TRPC1 alone increased the basal activity by À22.9±1.4 pA/pF, showed significant activation by Oxo-M (7.8 ± 0.3 pA/pF) and little inhibition by amiloride (12.8 ± 0.9%; Fig 4C,G,I -K). Co-transfection of TRPP2 and TRPC1 yielded an increase in the basal activity by À63.3 ± 2.1 pA/pF, which was higher than the additive effect (À41.2 pA/pF) of TRPP2 and TRPC1 (new property; Fig 4D,H,I ), higher activation by Oxo-M compared with TRPC1 alone (11.8±0.7 pA/pF; TRPC1-specific property; Fig 4J) and inhibition by amiloride (63.4 ± 2.4%; TRPP2-specific property; Fig 4K) . In addition, co-expression of TRPP2 and TRPC1 resulted in a positive shift of approximately 8 mV in the reversal potential (E rev ), which was not observed with TRPP2 or TRPC1 alone (Fig 4E-H) . Extracellular cation substitution experiments showed that (N) Na þ and Ca 2 þ permeability profiles of TRPP2, TRPC1 and TRPP2/TRPC1 in mIMCD3 cells. mIMCD, murine inner medullary collecting duct; Oxo-M, oxotremorine-M; TRP, transient receptor potential.
A new receptor-operated TRP channel C.-X. Bai et al co-transfection of TRPP2 and TRPC1 resulted in the formation of a channel with a higher permeability ratio of Ca 2 þ to Na þ compared to transfection of either of the channels alone (Fig 4L-N; new property) . Next, we performed loss-of-function experiments to find a functional interaction between native TRPP2 and TRPC1 in mIMCD3 cells. Cells were transiently transfected with TRPP2-D511V, I-mfa, a known inhibitor of TRPC1-specific current (Ma et al, 2003) , or a TRPC1-specific short hairpin RNA interference (RNAi) construct (shRNAi TRPC1 ). The silencing efficiency of shRNAi TRPC1 towards transfected and native mouse TRPC1 was shown in human embryonic kidney (HEK) 293T and mIMCD3 cells, respectively ( supplementary Fig 4 online) . All these constructs reduced basal currents (Fig 5A-H; supplementary  Fig 5 online) , consistent with the idea that TRPP2 and TRPC1 contributed to these currents. (I) Effect of amiloride (500 mM) on basal currents (at À100 mV) of mIMCD3 cells transfected with CD8 (mock, n ¼ 5), TRPP2-D511V (n ¼ 7), shRNAi TRPC1 (n ¼ 7) or TRPP2-D511V and shRNAi TRPC1 (n ¼ 7). (J) Summary data of amiloride-sensitive current in cell groups shown in (I). *Po0.05. (K) Time course of 10 mM Oxo-M-induced current (at À100 mV) in mIMCD3 cells transfected with CD8 (mock, n ¼ 6), TRPP2-D511V (n ¼ 7), shRNAi TRPC1 (n ¼ 7) or TRPP2-D511V and shRNAi TRPC1 (n ¼ 6). (L) Summary data of Oxo-M-induced current in cell groups shown in (K). *Po0.05. mIMCD, murine inner medullary collecting duct; Oxo-M, oxotremorine-M; shRNAi; TRPC1-specific short hairpin RNA interference construct; TRP, transient receptor potential; D511V, construct-dead mutant.
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As we knew that TRPP2 and heteromeric TRPP2/TRPC1-but not TRPC1-was amiloride sensitive, we used amiloride to test for the existence of native TRPP2/TRPC1 current in mIMCD3 cells. Fig 5I,J shows that knockdown of native TRPC1 reduced wholecell amiloride-sensitive current by 5.4 pA/pF (from 17.2 ± 0.6 pA/pF in mock-transfected cells to 11.8 ± 0.2 pA/pF in shRNAi TRPC1 -transfected cells). We reasoned that this reduction was due to the loss of an amiloride-sensitive pool of TRPC1. This pool is likely to contain TRPC1/TRPP2 because overexpression of TRPP2-D511V suppressed amiloride-sensitive current to levels similar to that in cells transfected with TRPP2-D511V and shRNAi TRPC1 , indicating that TRPP2 and interacting proteins accounted for 76% of all amiloride-sensitive current in mIMCD3 cells (from 17.2 ± 0.6 pA/pF in mock-transfected cells to 3.5±0.4 pA/pF in TRPP2-D511V-transfected cells). The residual current was carried by proteins unrelated to TRPP2 or TRPC1 (4.0 ± 0.3 pA/pF; Fig 5J) . Singlechannel analysis showed that TRPP2/TRPC1, but not TRPP2 alone or in association with PKD1, was activated secondarily to GPCR activation. Consistently, overexpression of TRPP2-D511V suppressed Oxo-M-induced currents, indicating that native TRPP2 was likely to participate in these currents (Fig 5K,L) . It should be noted that TRPP2-D511V did not inhibit total TRPC1 activity but only the pool of TRPC1 associated with TRPP2 (compare basal current density before and after amiloride in cells transfected with TRPP2-D511V alone, and TRPP2-D511V and shRNAi TRPC1 ; Fig 5I) . Overall, these loss-of-function experiments in mIMCD3 cells were consistent with the existence of a native TRPP2/TRPC1 channel and the involvement of this channel in GPCR-induced currents.
TRPP2 and TRPC1 in kidney cells
We tested whether TRPC1 would be present and colocalize with TRPP2 in primary cilia. Immunofluorescence staining of LLC-PK1 (pig kidney epithelial cells) and mIMCD3 cells showed the expression of TRPC1 in the cilium and its colocalization with TRPP2 (supplementary Fig 6A online) . Consistently, supplementary Fig 6B online shows that a mouse polyclonal antibody raised against the amino-terminal cytosolic region of human TRPC1 (anti-TRPC1) was able to immunoprecipitate native TRPP2 from rat kidney membrane lysates.
Here, we have shown that TRPP2 and TRPC1 assemble into a new GPCR-activated channel with biophysical properties distinct from that of individual channels. This conclusion is supported by biochemical, and gain-of-function and loss-of-function experiments using single-channel and whole-cell analysis in two different cell culture systems. TRPP2/TRPC1 mediates native GPCR-activated currents and might explain the role of TRPP2 in mechanosensation and cilium-based Ca 2 þ signalling.
TRPP2 has been postulated to function as a mechanosensitive channel in kidney epithelial cells. Our data indirectly support such a role but cast doubt on the role of mechanosensation in ADPKD. It was recently shown that endothelial cells detect fluidshear stress through activation of BK (Chachisvilis et al, 2006) , indicating that GPCR-dependent signalling might actually underlie mechanotransduction. Mechanical bending of the primary cilium has been shown to induce Ca 2 þ influx through the activation of phospholipase C (Praetorius & Spring, 2003) . Therefore, it is possible that fluid-shear stress or cilium bending activates TRPP2/TRPC1 either directly (Maroto et al, 2005) or indirectly through the activation of plasma membrane GPCRs. However, an initial analysis of mice lacking TRPC1 did not show obvious symptoms of PKD. Thus, we would like to propose that defective mechanosensation might not be the sole underlying cause of ADPKD. This is now supported by whole animal studies in which delayed inactivation of PKD1 or polaris resulted in mild forms of PKD. It is thus possible that PKD1/TRPP2 might mediate functions other than mechanosensation during kidney development that are crucial for normal tubulogenesis.
METHODS
DNA constructs. mPKD1, TRPP2-D511 and I-mfa cDNAs have been described previously (Delmas et al, 2002a; Ma et al, 2003 Ma et al, , 2005 . TRPP2-D511V is a pathogenic missense variant of TRPP2 lacking channel activity but maintaining hetero-and homomultimerization (Reynolds et al, 1999) . mTRPP2 and mTRPC1 were obtained from Open Biosystems (Huntsville, AL, USA) as full-length expressed sequence tags. shRNAi TRPC1 was obtained by cloning the mTRPC1 sequence 5 0 -GTGGTGGCTCACAACAAGT-3 0 into pSUPER-retro (Oligoengine Inc., Seattle, WA, USA) RNAi vector. The human m1AChR cDNA was cloned into pSV-2 neo vector. Intranuclear cDNA delivery. DNA plasmids were diluted to either 100 or 300 ng/ml in a KCl-based Ca 2 þ -free internal solution (pH 7.3) containing 0.2% fluorescein isothiocyanate-dextran (70 kDa) and were pressure-injected into the nucleus of neurons, as described previously (Delmas et al, 2002a) . Cells were maintained in culture for a further 2 days before recording. Outside-out perforated microvesicles. Microvesicles were obtained as described in the supplementary information online (Delmas et al, 2002b) . Whole-cell recordings. Currents in mIMCD3 cells were recorded by using the perforated whole-cell configuration as described in the supplementary information online.
Immunofluorescence and immunoprecipitation. LLC-PK1 or mIMCD3 cells were grown on glass coverslips for 7 days to allow cilia formation and immunostained as described in the supplementary information online. Immunocomplexes from rat kidney tissues were prepared as described previously (Tsiokas et al, 1999) and as detailed in the supplementary information online. Supplementary information is available at EMBO reports online (http://www.emboreports.org).
